BKYI — BIO-key International Income Statement
0.000.00%
- $2.98m
- $2.57m
- $7.75m
- 18
- 31
- 20
- 12
Annual income statement for BIO-key International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.27 | 2.84 | 5.11 | 7.02 | 7.75 |
Cost of Revenue | |||||
Gross Profit | -0.194 | 2.04 | 3.44 | 4.58 | 1.43 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 15.8 | 8.54 | 10.1 | 17.4 | 16.6 |
Operating Profit | -13.5 | -5.7 | -4.94 | -10.4 | -8.83 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.6 | -9.67 | -5.07 | -11.9 | -8.66 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.6 | -9.67 | -5.07 | -11.9 | -8.52 |
Net Income Before Extraordinary Items | |||||
Net Income | -14.6 | -9.67 | -5.07 | -11.9 | -8.52 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.6 | -9.79 | -5.07 | -11.9 | -8.52 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -77.3 | -35.6 | -11.7 | -23 | -15.2 |